# Probiotic Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotic-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Probiotic Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-05
Reviewed by: Migaku Evidence Review
# Probiotic Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Probiotic Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020–2026) | systematic review | 1 | 2026-05-08 | 10.3390/nu18101508 |
| Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis | systematic review | 1 | 2026-02-06 | 10.3389/fcvm.2026.1707408 |

## What The Sources Report

- Metabolically dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is an emerging chronic hepatic condition that is being diagnosed among 30-38% of adults worldwide, with prevalence in Europe reaching 25-30%. [Jurek Joanna Michalina (2026); evidence level 1]
- Under this updated framework, individuals previously classified as having NAFLD now fall within the MASLD definition, which replaces the earlier exclusionary criterion based solely on non-alcohol intake with broader cardiometabolic risk factors. [Jurek Joanna Michalina (2026); evidence level 1]
- The incidence of CHD rises with advancing age, with a notably increased risk observed in men aged 45 years or older and women aged 55 years or postmenopausal. [Zhong Yan (2026); evidence level 1]
- Hypertension, hyperlipidemia, and hyperglycemia are well-established as the three major modifiable risk factors for CHD. [Zhong Yan (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For probiotic blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Jurek Joanna Michalina (2026). Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020–2026). DOI: 10.3390/nu18101508. PMCID: PMC13209196. PMID: 42196968. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13209196/
- Zhong Yan (2026). Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. DOI: 10.3389/fcvm.2026.1707408. PMCID: PMC12920485. PMID: 41725935. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12920485/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.